Bridgeway Capital Management’s Oruka Therapeutics, Inc. Common Stock ORKA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-3,912
| Closed | -$94.4K | – | 1428 |
|
|
2023
Q3 | $94.4K | Hold |
3,912
| – | – | ﹤0.01% | 1239 |
|
|
2023
Q2 | $95.3K | Hold |
3,912
| – | – | ﹤0.01% | 1262 |
|
|
2023
Q1 | $93.4K | Hold |
3,912
| – | – | ﹤0.01% | 1250 |
|
|
2022
Q4 | $111K | Hold |
3,912
| – | – | ﹤0.01% | 1202 |
|
|
2022
Q3 | $97K | Hold |
3,912
| – | – | ﹤0.01% | 1273 |
|
|
2022
Q2 | $117K | Buy |
3,912
+2,083
| +114% | +$62.3K | ﹤0.01% | 1202 |
|
|
2022
Q1 | $50K | Buy |
+1,829
| New | +$50K | ﹤0.01% | 1289 |
|
|
2014
Q4 | – | Sell |
-79
| Closed | -$150K | – | 1523 |
|
|
2014
Q3 | $150K | Hold |
79
| – | – | ﹤0.01% | 1375 |
|
|
2014
Q2 | $175K | Hold |
79
| – | – | ﹤0.01% | 1350 |
|
|
2014
Q1 | $223K | Hold |
79
| – | – | 0.01% | 1300 |
|
|
2013
Q4 | $202K | Buy |
+79
| New | +$202K | 0.01% | 1294 |
|